These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2698355)

  • 1. Persistence of anti-islet ADCC after manifestation of type-1 (insulin-dependent) diabetes.
    Köhler E; Knospe S; Besch W; Michaelis D; Rjasanowski I
    Exp Clin Endocrinol; 1989; 94(3):357-62. PubMed ID: 2698355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
    Köhler E; Knospe S; Hahn HJ; Roemer KG; Diamantstein T
    Exp Clin Endocrinol; 1989 May; 93(2-3):143-6. PubMed ID: 2673806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lymphocytes and serum from probands before and after manifestation of type 1 (insulin-dependent) diabetes on rat islets in vitro.
    Köhler E; Knospe S; Rjasanowski I; Michaelis D
    Exp Clin Endocrinol; 1988 Dec; 92(2):182-8. PubMed ID: 3072214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune reactions against islets of Langerhans in diabetes-prone BB rats.
    Knospe S; Köhler E; Klöting I
    Exp Clin Endocrinol; 1987 Aug; 89(3):290-6. PubMed ID: 3311775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
    Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
    Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune reactions against rat pancreatic islets mediated by antibodies from type I diabetic patients.
    Kruschel B; Jahr H; Marx S; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):635-9. PubMed ID: 6383367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study.
    Ziegler B; Klöting I; Besch W; Ziegler M; Hahn HJ
    Diabetes Res; 1987 Feb; 4(2):67-72. PubMed ID: 3555954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sera obtained from children with insulin-dependent diabetes mellitus on cultivated islet cells: cytotoxicity and insulin release.
    Sadovnikova NV; Pankov YA; Fedotov VP; Czernushkina AV; Zhukovsky MA; Shcherbacheva LN
    Exp Clin Endocrinol; 1989 May; 93(2-3):166-72. PubMed ID: 2673810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of strong association between residual human C-peptide secretion and islet cell antibodies, complement-dependent antibody-mediated cytotoxicity, and HLA antigens in newly diagnosed type I diabetics.
    Michaelis D; Rjasanowski I; Hehmke B; Kohnert KD; Hildmann W; Keilacker H; Richter KV
    Biomed Biochim Acta; 1985; 44(1):99-106. PubMed ID: 3888215
    [No Abstract]   [Full Text] [Related]  

  • 15. A follow-up study of cell-mediated cytotoxicity and beta cell function in type I diabetes.
    Bierwolf B; Verlohren HJ; Lohmann D; Lampeter EF; Krug J
    Exp Clin Endocrinol; 1987 Aug; 89(3):363-7. PubMed ID: 3311778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of islet cell surface antibodies and antibody-dependent cell-mediated cytotoxicity (ADCC) of mononuclear cells in HLA-typed patients with high diabetes risk.
    Rjasanowski I; Michaelis D; Dietz H; Witt S; Köhler E; Knospe S
    Exp Clin Endocrinol; 1985 Feb; 85(1):70-4. PubMed ID: 3886413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of serum from diabetes-prone BB/OK rats on neonatal rat pancreatic islets and islet cell suspensions.
    Schröder D; Hehmke B; Klöting I; Besch W
    Exp Clin Endocrinol; 1989 May; 93(2-3):187-92. PubMed ID: 2673813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated.
    Koevary SB
    Diabetes Res; 1990 Mar; 13(3):133-8. PubMed ID: 2091881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of islet isografts despite cytotoxicity against pancreatic islets measured in vitro.
    Ziegler B; Köhler E; Klöting I; Besch W; Ziegler M
    Exp Clin Endocrinol; 1990 Feb; 95(1):31-8. PubMed ID: 2139850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.